Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. HD
6. SPY
7. MRK
8. DVLT
9. MRCY
10. LOW

Go back to Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study
ORAMED (NASDAQ: ORMP) Delayed: 4.79 +0.01 (0.21%)
Previous Close $4.78    52 Week High $10.74 
Open $4.83    52 Week Low $5.60 
Day High $4.94    P/E N/A 
Day Low $4.70    EPS $-0.59 
Volume 363,166       

ORAMED (NASDAQ: ORMP) Delayed: 4.79 +0.01 (0.21%)
Previous Close $4.78    52 Week High $10.74 
Open $4.83    52 Week Low $5.60 
Day High $4.94    P/E N/A 
Day Low $4.70    EPS $-0.59 
Volume 363,166